![](/img/cover-not-exists.png)
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2–17-year-old children with asplenia or splenic dysfunction: A phase 3 study
Szenborn, L., Osipova, I.V., Czajka, H., Kharit, S.M., Jackowska, T., François, N., Habib, M.A., Borys, D.Language:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2017.08.039
Date:
August, 2017
File:
PDF, 392 KB
english, 2017